Edwards Lifesciences (EW) Other Accumulated Expenses (2009 - 2014)

Edwards Lifesciences has reported Other Accumulated Expenses for 6 years, with the latest figure at $72.6 million in Q4 2014.

• On a quarterly basis, Other Accumulated Expenses rose 2.4% year-over-year to $72.6 million in Q4 2014; TTM through Dec 2014 was $72.6 million, a 2.4% increase from a year earlier, with the FY2014 full-year figure at $72.6 million, up 2.4% from the prior year.
• Other Accumulated Expenses was $72.6 million for Q4 2014 at Edwards Lifesciences, down from $82.8 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $82.8 million in Q3 2014, with the low at $58.4 million in Q4 2011.
• Average Other Accumulated Expenses over 5 years is $69.6 million, with a median of $71.3 million recorded in 2012.
• The sharpest annual moves came in 2011 and 2012: Other Accumulated Expenses dropped 4.58% in 2011, then rose 22.77% in 2012.
• Over 5 years, Other Accumulated Expenses stood at $61.2 million in 2010, then dropped by 4.58% to $58.4 million in 2011, then advanced by 22.77% to $71.7 million in 2012, then declined by 1.12% to $70.9 million in 2013, then climbed by 2.4% to $72.6 million in 2014.
• The last three Other Accumulated Expenses figures came in at $72.6 million (Q4 2014), $82.8 million (Q3 2014), and $70.9 million (Q4 2013), per Business Quant data.